instruction stringlengths 34 186 | input stringlengths 2.02k 93.8k | output stringlengths 2 418 | meta_questiontype stringclasses 6
values | meta_inputlicense stringclasses 6
values | meta_pmid stringlengths 8 8 | meta_safetyreportid int64 9.51M 21M | meta_articlepubdate stringlengths 4 10 |
|---|---|---|---|---|---|---|---|
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Plasma cell myeloma'. | Case Report: Lenalidomide as a Second-Line Treatment for Bortezomib-Ineffective Nephrotic Syndrome Caused by LCDD: 2 Case Reports and a Literature Review.
Background: Light-chain deposition disease (LCDD) is a rare systemic disorder characterized by the deposition of monoclonal light chains in organs. The kidney is a p... | BORTEZOMIB, CYCLOPHOSPHAMIDE, DEXAMETHASONE, IXAZOMIB, LENALIDOMIDE, PREDNISOLONE, TACROLIMUS | DrugsGivenReaction | CC BY | 34692719 | 20,231,627 | 2021 |
What was the dosage of drug 'IXAZOMIB'? | Case Report: Lenalidomide as a Second-Line Treatment for Bortezomib-Ineffective Nephrotic Syndrome Caused by LCDD: 2 Case Reports and a Literature Review.
Background: Light-chain deposition disease (LCDD) is a rare systemic disorder characterized by the deposition of monoclonal light chains in organs. The kidney is a p... | UNK, IRD THERAPY | DrugDosageText | CC BY | 34692719 | 20,231,627 | 2021 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Condition aggravated'. | Removal of COVID-19 Spike Protein, Whole Virus, Exosomes, and Exosomal MicroRNAs by the Hemopurifier® Lectin-Affinity Cartridge in Critically Ill Patients With COVID-19 Infection.
Coronavirus-19 (COVID-19) has rapidly spread throughout the world resulting in a significant amount of morbidity and mortality. Despite adva... | BARICITINIB, DEXAMETHASONE, REMDESIVIR | DrugsGivenReaction | CC BY | 34692735 | 20,263,368 | 2021 |
What was the dosage of drug 'BARICITINIB'? | Removal of COVID-19 Spike Protein, Whole Virus, Exosomes, and Exosomal MicroRNAs by the Hemopurifier® Lectin-Affinity Cartridge in Critically Ill Patients With COVID-19 Infection.
Coronavirus-19 (COVID-19) has rapidly spread throughout the world resulting in a significant amount of morbidity and mortality. Despite adva... | UNKNOWN | DrugDosageText | CC BY | 34692735 | 20,263,368 | 2021 |
What was the dosage of drug 'DEXAMETHASONE'? | Removal of COVID-19 Spike Protein, Whole Virus, Exosomes, and Exosomal MicroRNAs by the Hemopurifier® Lectin-Affinity Cartridge in Critically Ill Patients With COVID-19 Infection.
Coronavirus-19 (COVID-19) has rapidly spread throughout the world resulting in a significant amount of morbidity and mortality. Despite adva... | UNKNOWN | DrugDosageText | CC BY | 34692735 | 20,263,368 | 2021 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Alanine aminotransferase increased'. | Case Report: Difficulties in the Treatment of a 12-Year-Old Patient With Homozygous Familial Hypercholesterolemia, Compound Heterozygous Form - 5 Years Follow-Up.
The literature review we conducted reveals the limited use of proprotein convertase subtilisin/kexin type 9-inhibitors (PCSK9i) in children with familial hyp... | ATORVASTATIN CALCIUM, EZETIMIBE | DrugsGivenReaction | CC BY | 34692794 | 20,155,992 | 2021 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Blood creatine phosphokinase increased'. | Case Report: Difficulties in the Treatment of a 12-Year-Old Patient With Homozygous Familial Hypercholesterolemia, Compound Heterozygous Form - 5 Years Follow-Up.
The literature review we conducted reveals the limited use of proprotein convertase subtilisin/kexin type 9-inhibitors (PCSK9i) in children with familial hyp... | ATORVASTATIN CALCIUM, EZETIMIBE | DrugsGivenReaction | CC BY | 34692794 | 20,155,992 | 2021 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Drug intolerance'. | Case Report: Difficulties in the Treatment of a 12-Year-Old Patient With Homozygous Familial Hypercholesterolemia, Compound Heterozygous Form - 5 Years Follow-Up.
The literature review we conducted reveals the limited use of proprotein convertase subtilisin/kexin type 9-inhibitors (PCSK9i) in children with familial hyp... | ATORVASTATIN CALCIUM, EZETIMIBE | DrugsGivenReaction | CC BY | 34692794 | 20,155,992 | 2021 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Muscular weakness'. | Case Report: Difficulties in the Treatment of a 12-Year-Old Patient With Homozygous Familial Hypercholesterolemia, Compound Heterozygous Form - 5 Years Follow-Up.
The literature review we conducted reveals the limited use of proprotein convertase subtilisin/kexin type 9-inhibitors (PCSK9i) in children with familial hyp... | ATORVASTATIN CALCIUM, EZETIMIBE | DrugsGivenReaction | CC BY | 34692794 | 20,155,992 | 2021 |
What was the outcome of reaction 'Alanine aminotransferase increased'? | Case Report: Difficulties in the Treatment of a 12-Year-Old Patient With Homozygous Familial Hypercholesterolemia, Compound Heterozygous Form - 5 Years Follow-Up.
The literature review we conducted reveals the limited use of proprotein convertase subtilisin/kexin type 9-inhibitors (PCSK9i) in children with familial hyp... | Recovered | ReactionOutcome | CC BY | 34692794 | 20,155,992 | 2021 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Detachment of retinal pigment epithelium'. | Exacerbation of pigment epithelial detachment following aflibercept: A case of bevacizumab rescue.
We describe a 61-year-old female patient with a retinal pigment epithelial detachment (PED) of the left eye in the setting of neovascular aged-macular degeneration (nAMD) with unanticipated responses to aflibercept and be... | AFLIBERCEPT | DrugsGivenReaction | CC BY-NC-ND | 34693076 | 20,414,776 | 2021-12 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Subretinal fluid'. | Exacerbation of pigment epithelial detachment following aflibercept: A case of bevacizumab rescue.
We describe a 61-year-old female patient with a retinal pigment epithelial detachment (PED) of the left eye in the setting of neovascular aged-macular degeneration (nAMD) with unanticipated responses to aflibercept and be... | AFLIBERCEPT | DrugsGivenReaction | CC BY-NC-ND | 34693076 | 20,414,776 | 2021-12 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Visual impairment'. | Exacerbation of pigment epithelial detachment following aflibercept: A case of bevacizumab rescue.
We describe a 61-year-old female patient with a retinal pigment epithelial detachment (PED) of the left eye in the setting of neovascular aged-macular degeneration (nAMD) with unanticipated responses to aflibercept and be... | AFLIBERCEPT | DrugsGivenReaction | CC BY-NC-ND | 34693076 | 20,414,776 | 2021-12 |
What was the administration route of drug 'AFLIBERCEPT'? | Exacerbation of pigment epithelial detachment following aflibercept: A case of bevacizumab rescue.
We describe a 61-year-old female patient with a retinal pigment epithelial detachment (PED) of the left eye in the setting of neovascular aged-macular degeneration (nAMD) with unanticipated responses to aflibercept and be... | Intraocular | DrugAdministrationRoute | CC BY-NC-ND | 34693076 | 20,414,776 | 2021-12 |
What was the outcome of reaction 'Detachment of retinal pigment epithelium'? | Exacerbation of pigment epithelial detachment following aflibercept: A case of bevacizumab rescue.
We describe a 61-year-old female patient with a retinal pigment epithelial detachment (PED) of the left eye in the setting of neovascular aged-macular degeneration (nAMD) with unanticipated responses to aflibercept and be... | Recovered | ReactionOutcome | CC BY-NC-ND | 34693076 | 20,414,776 | 2021-12 |
What was the outcome of reaction 'Subretinal fluid'? | Exacerbation of pigment epithelial detachment following aflibercept: A case of bevacizumab rescue.
We describe a 61-year-old female patient with a retinal pigment epithelial detachment (PED) of the left eye in the setting of neovascular aged-macular degeneration (nAMD) with unanticipated responses to aflibercept and be... | Recovered | ReactionOutcome | CC BY-NC-ND | 34693076 | 20,414,776 | 2021-12 |
What was the outcome of reaction 'Visual impairment'? | Exacerbation of pigment epithelial detachment following aflibercept: A case of bevacizumab rescue.
We describe a 61-year-old female patient with a retinal pigment epithelial detachment (PED) of the left eye in the setting of neovascular aged-macular degeneration (nAMD) with unanticipated responses to aflibercept and be... | Recovered | ReactionOutcome | CC BY-NC-ND | 34693076 | 20,414,776 | 2021-12 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Infusion site pain'. | Case report: Stepwise transition from subcutaneous treprostinil to epoprostenol in high-risk pulmonary arterial hypertension.
Idiopathic pulmonary arterial hypertension is associated with high morbidity and mortality. In recent years, the use of targeted therapies has led to an improvement in prognosis. Prostacyclin an... | ACENOCOUMAROL, MACITENTAN, SPIRONOLACTONE, TREPROSTINIL | DrugsGivenReaction | CC BY-NC | 34693197 | 20,031,329 | 2021-10 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Infusion site reaction'. | Case report: Stepwise transition from subcutaneous treprostinil to epoprostenol in high-risk pulmonary arterial hypertension.
Idiopathic pulmonary arterial hypertension is associated with high morbidity and mortality. In recent years, the use of targeted therapies has led to an improvement in prognosis. Prostacyclin an... | ACENOCOUMAROL, MACITENTAN, SPIRONOLACTONE, TREPROSTINIL | DrugsGivenReaction | CC BY-NC | 34693197 | 20,031,329 | 2021-10 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Oedema peripheral'. | Case report: Stepwise transition from subcutaneous treprostinil to epoprostenol in high-risk pulmonary arterial hypertension.
Idiopathic pulmonary arterial hypertension is associated with high morbidity and mortality. In recent years, the use of targeted therapies has led to an improvement in prognosis. Prostacyclin an... | ACENOCOUMAROL, MACITENTAN, SPIRONOLACTONE, TREPROSTINIL | DrugsGivenReaction | CC BY-NC | 34693197 | 20,031,329 | 2021-10 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Pericardial effusion'. | Case report: Stepwise transition from subcutaneous treprostinil to epoprostenol in high-risk pulmonary arterial hypertension.
Idiopathic pulmonary arterial hypertension is associated with high morbidity and mortality. In recent years, the use of targeted therapies has led to an improvement in prognosis. Prostacyclin an... | ACENOCOUMAROL, MACITENTAN, SPIRONOLACTONE, TREPROSTINIL | DrugsGivenReaction | CC BY-NC | 34693197 | 20,031,329 | 2021-10 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Pulmonary arterial hypertension'. | Case report: Stepwise transition from subcutaneous treprostinil to epoprostenol in high-risk pulmonary arterial hypertension.
Idiopathic pulmonary arterial hypertension is associated with high morbidity and mortality. In recent years, the use of targeted therapies has led to an improvement in prognosis. Prostacyclin an... | ACENOCOUMAROL, MACITENTAN, SPIRONOLACTONE, TREPROSTINIL | DrugsGivenReaction | CC BY-NC | 34693197 | 20,031,329 | 2021-10 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Sinus tachycardia'. | Case report: Stepwise transition from subcutaneous treprostinil to epoprostenol in high-risk pulmonary arterial hypertension.
Idiopathic pulmonary arterial hypertension is associated with high morbidity and mortality. In recent years, the use of targeted therapies has led to an improvement in prognosis. Prostacyclin an... | ACENOCOUMAROL, MACITENTAN, SPIRONOLACTONE, TREPROSTINIL | DrugsGivenReaction | CC BY-NC | 34693197 | 20,031,329 | 2021-10 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Subcutaneous drug absorption impaired'. | Case report: Stepwise transition from subcutaneous treprostinil to epoprostenol in high-risk pulmonary arterial hypertension.
Idiopathic pulmonary arterial hypertension is associated with high morbidity and mortality. In recent years, the use of targeted therapies has led to an improvement in prognosis. Prostacyclin an... | ACENOCOUMAROL, MACITENTAN, SPIRONOLACTONE, TREPROSTINIL | DrugsGivenReaction | CC BY-NC | 34693197 | 20,031,329 | 2021-10 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Therapy non-responder'. | Case report: Stepwise transition from subcutaneous treprostinil to epoprostenol in high-risk pulmonary arterial hypertension.
Idiopathic pulmonary arterial hypertension is associated with high morbidity and mortality. In recent years, the use of targeted therapies has led to an improvement in prognosis. Prostacyclin an... | ACENOCOUMAROL, MACITENTAN, SPIRONOLACTONE, TREPROSTINIL | DrugsGivenReaction | CC BY-NC | 34693197 | 20,031,329 | 2021-10 |
What is the weight of the patient? | Case report: Stepwise transition from subcutaneous treprostinil to epoprostenol in high-risk pulmonary arterial hypertension.
Idiopathic pulmonary arterial hypertension is associated with high morbidity and mortality. In recent years, the use of targeted therapies has led to an improvement in prognosis. Prostacyclin an... | 55 kg. | Weight | CC BY-NC | 34693197 | 20,180,826 | 2021-10 |
What was the administration route of drug 'TREPROSTINIL'? | Case report: Stepwise transition from subcutaneous treprostinil to epoprostenol in high-risk pulmonary arterial hypertension.
Idiopathic pulmonary arterial hypertension is associated with high morbidity and mortality. In recent years, the use of targeted therapies has led to an improvement in prognosis. Prostacyclin an... | Subcutaneous | DrugAdministrationRoute | CC BY-NC | 34693197 | 20,031,329 | 2021-10 |
What was the outcome of reaction 'Pericardial effusion'? | Case report: Stepwise transition from subcutaneous treprostinil to epoprostenol in high-risk pulmonary arterial hypertension.
Idiopathic pulmonary arterial hypertension is associated with high morbidity and mortality. In recent years, the use of targeted therapies has led to an improvement in prognosis. Prostacyclin an... | Recovered | ReactionOutcome | CC BY-NC | 34693197 | 20,031,329 | 2021-10 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Agitation'. | Prolonged post-ictal atrial fibrillation following seizures.
It is well known that several types of cardiac arrhythmias can occur after a seizure, with ictal sinus tachycardia being the most common. However, post-ictal atrial fibrillation (PIAF) is a rare phenomenon with significant clinical implications. We describe t... | LEVETIRACETAM | DrugsGivenReaction | CC BY-NC-ND | 34693244 | 20,523,422 | 2021 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Drug interaction'. | Index finger pointing posture in a patient with drug-induced foot tremor.
A 41-year-old woman who had been taking paroxetine began taking tramadol for bilateral ankle pain. A few days later, the patient presented acutely with both feet tremors. During a mental arithmetic task, index-finger pointing posture briefly appe... | PAROXETINE, TRAMADOL | DrugsGivenReaction | CC BY | 34693272 | 20,460,008 | 2021 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Dystonia'. | Index finger pointing posture in a patient with drug-induced foot tremor.
A 41-year-old woman who had been taking paroxetine began taking tramadol for bilateral ankle pain. A few days later, the patient presented acutely with both feet tremors. During a mental arithmetic task, index-finger pointing posture briefly appe... | PAROXETINE, TRAMADOL | DrugsGivenReaction | CC BY | 34693272 | 20,429,720 | 2021 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Hyperreflexia'. | Index finger pointing posture in a patient with drug-induced foot tremor.
A 41-year-old woman who had been taking paroxetine began taking tramadol for bilateral ankle pain. A few days later, the patient presented acutely with both feet tremors. During a mental arithmetic task, index-finger pointing posture briefly appe... | PAROXETINE, TRAMADOL | DrugsGivenReaction | CC BY | 34693272 | 20,460,008 | 2021 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Joint hyperextension'. | Index finger pointing posture in a patient with drug-induced foot tremor.
A 41-year-old woman who had been taking paroxetine began taking tramadol for bilateral ankle pain. A few days later, the patient presented acutely with both feet tremors. During a mental arithmetic task, index-finger pointing posture briefly appe... | PAROXETINE, TRAMADOL | DrugsGivenReaction | CC BY | 34693272 | 20,460,008 | 2021 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Movement disorder'. | Index finger pointing posture in a patient with drug-induced foot tremor.
A 41-year-old woman who had been taking paroxetine began taking tramadol for bilateral ankle pain. A few days later, the patient presented acutely with both feet tremors. During a mental arithmetic task, index-finger pointing posture briefly appe... | PAROXETINE, TRAMADOL | DrugsGivenReaction | CC BY | 34693272 | 20,460,008 | 2021 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Posture abnormal'. | Index finger pointing posture in a patient with drug-induced foot tremor.
A 41-year-old woman who had been taking paroxetine began taking tramadol for bilateral ankle pain. A few days later, the patient presented acutely with both feet tremors. During a mental arithmetic task, index-finger pointing posture briefly appe... | PAROXETINE, TRAMADOL | DrugsGivenReaction | CC BY | 34693272 | 20,429,720 | 2021 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Serotonin syndrome'. | Index finger pointing posture in a patient with drug-induced foot tremor.
A 41-year-old woman who had been taking paroxetine began taking tramadol for bilateral ankle pain. A few days later, the patient presented acutely with both feet tremors. During a mental arithmetic task, index-finger pointing posture briefly appe... | PAROXETINE, TRAMADOL | DrugsGivenReaction | CC BY | 34693272 | 20,460,008 | 2021 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Tremor'. | Index finger pointing posture in a patient with drug-induced foot tremor.
A 41-year-old woman who had been taking paroxetine began taking tramadol for bilateral ankle pain. A few days later, the patient presented acutely with both feet tremors. During a mental arithmetic task, index-finger pointing posture briefly appe... | PAROXETINE, TRAMADOL | DrugsGivenReaction | CC BY | 34693272 | 20,460,008 | 2021 |
What was the outcome of reaction 'Drug interaction'? | Index finger pointing posture in a patient with drug-induced foot tremor.
A 41-year-old woman who had been taking paroxetine began taking tramadol for bilateral ankle pain. A few days later, the patient presented acutely with both feet tremors. During a mental arithmetic task, index-finger pointing posture briefly appe... | Recovered | ReactionOutcome | CC BY | 34693272 | 20,460,008 | 2021 |
What was the outcome of reaction 'Dystonia'? | Index finger pointing posture in a patient with drug-induced foot tremor.
A 41-year-old woman who had been taking paroxetine began taking tramadol for bilateral ankle pain. A few days later, the patient presented acutely with both feet tremors. During a mental arithmetic task, index-finger pointing posture briefly appe... | Recovered | ReactionOutcome | CC BY | 34693272 | 20,429,720 | 2021 |
What was the outcome of reaction 'Hyperreflexia'? | Index finger pointing posture in a patient with drug-induced foot tremor.
A 41-year-old woman who had been taking paroxetine began taking tramadol for bilateral ankle pain. A few days later, the patient presented acutely with both feet tremors. During a mental arithmetic task, index-finger pointing posture briefly appe... | Recovered | ReactionOutcome | CC BY | 34693272 | 20,460,008 | 2021 |
What was the outcome of reaction 'Joint hyperextension'? | Index finger pointing posture in a patient with drug-induced foot tremor.
A 41-year-old woman who had been taking paroxetine began taking tramadol for bilateral ankle pain. A few days later, the patient presented acutely with both feet tremors. During a mental arithmetic task, index-finger pointing posture briefly appe... | Recovered | ReactionOutcome | CC BY | 34693272 | 20,460,008 | 2021 |
What was the outcome of reaction 'Movement disorder'? | Index finger pointing posture in a patient with drug-induced foot tremor.
A 41-year-old woman who had been taking paroxetine began taking tramadol for bilateral ankle pain. A few days later, the patient presented acutely with both feet tremors. During a mental arithmetic task, index-finger pointing posture briefly appe... | Recovered | ReactionOutcome | CC BY | 34693272 | 20,460,008 | 2021 |
What was the outcome of reaction 'Posture abnormal'? | Index finger pointing posture in a patient with drug-induced foot tremor.
A 41-year-old woman who had been taking paroxetine began taking tramadol for bilateral ankle pain. A few days later, the patient presented acutely with both feet tremors. During a mental arithmetic task, index-finger pointing posture briefly appe... | Recovered | ReactionOutcome | CC BY | 34693272 | 20,429,720 | 2021 |
What was the outcome of reaction 'Serotonin syndrome'? | Index finger pointing posture in a patient with drug-induced foot tremor.
A 41-year-old woman who had been taking paroxetine began taking tramadol for bilateral ankle pain. A few days later, the patient presented acutely with both feet tremors. During a mental arithmetic task, index-finger pointing posture briefly appe... | Recovered | ReactionOutcome | CC BY | 34693272 | 20,460,008 | 2021 |
What was the outcome of reaction 'Tremor'? | Index finger pointing posture in a patient with drug-induced foot tremor.
A 41-year-old woman who had been taking paroxetine began taking tramadol for bilateral ankle pain. A few days later, the patient presented acutely with both feet tremors. During a mental arithmetic task, index-finger pointing posture briefly appe... | Recovered | ReactionOutcome | CC BY | 34693272 | 20,460,008 | 2021 |
What was the administration route of drug 'HUMAN IMMUNOGLOBULIN G'? | Repetitive Immune-Mediated Noninfectious Endocarditis Necessitating 5 Mitral Valve Replacements.
We present a young patient who had to undergo 5 mitral valve replacements (MVR) because of a repetitive immune-mediated noninfectious endocarditis. The patient was treated with multiple anti-inflammatory drugs and high-dose... | Intravenous (not otherwise specified) | DrugAdministrationRoute | CC BY-NC-ND | 34693347 | 20,514,327 | 2021-10-06 |
What was the administration route of drug 'METHYLPREDNISOLONE'? | Repetitive Immune-Mediated Noninfectious Endocarditis Necessitating 5 Mitral Valve Replacements.
We present a young patient who had to undergo 5 mitral valve replacements (MVR) because of a repetitive immune-mediated noninfectious endocarditis. The patient was treated with multiple anti-inflammatory drugs and high-dose... | Intravenous (not otherwise specified) | DrugAdministrationRoute | CC BY-NC-ND | 34693347 | 20,514,327 | 2021-10-06 |
What was the administration route of drug 'PREDNISOLONE'? | Repetitive Immune-Mediated Noninfectious Endocarditis Necessitating 5 Mitral Valve Replacements.
We present a young patient who had to undergo 5 mitral valve replacements (MVR) because of a repetitive immune-mediated noninfectious endocarditis. The patient was treated with multiple anti-inflammatory drugs and high-dose... | Oral | DrugAdministrationRoute | CC BY-NC-ND | 34693347 | 20,514,327 | 2021-10-06 |
What was the administration route of drug 'PREDNISONE'? | Repetitive Immune-Mediated Noninfectious Endocarditis Necessitating 5 Mitral Valve Replacements.
We present a young patient who had to undergo 5 mitral valve replacements (MVR) because of a repetitive immune-mediated noninfectious endocarditis. The patient was treated with multiple anti-inflammatory drugs and high-dose... | Oral | DrugAdministrationRoute | CC BY-NC-ND | 34693347 | 20,586,836 | 2021-10-06 |
What was the administration route of drug 'RITUXIMAB'? | Repetitive Immune-Mediated Noninfectious Endocarditis Necessitating 5 Mitral Valve Replacements.
We present a young patient who had to undergo 5 mitral valve replacements (MVR) because of a repetitive immune-mediated noninfectious endocarditis. The patient was treated with multiple anti-inflammatory drugs and high-dose... | Subcutaneous | DrugAdministrationRoute | CC BY-NC-ND | 34693347 | 20,586,836 | 2021-10-06 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Heparin-induced thrombocytopenia'. | Incidentally Found Ascending Aortic Thrombus: Presentation and Management.
Aortic thrombus can be rare, requiring prompt recognition and management to prevent sequelae. Treatment modalities for aortic thrombus include systemic anticoagulation, endovascular, and/or surgical intervention. We present an incidental finding... | AMIODARONE HYDROCHLORIDE, AMITRIPTYLINE, BUPRENORPHINE, BUPROPION, HEPARIN SODIUM, RISPERIDONE | DrugsGivenReaction | CC BY-NC-ND | 34693348 | 20,467,705 | 2021-10-06 |
What was the outcome of reaction 'Heparin-induced thrombocytopenia'? | Incidentally Found Ascending Aortic Thrombus: Presentation and Management.
Aortic thrombus can be rare, requiring prompt recognition and management to prevent sequelae. Treatment modalities for aortic thrombus include systemic anticoagulation, endovascular, and/or surgical intervention. We present an incidental finding... | Recovered | ReactionOutcome | CC BY-NC-ND | 34693348 | 20,467,705 | 2021-10-06 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Product use in unapproved indication'. | Mitral Annular Disjunction Associated With Fatal Ventricular Arrhythmia in an Adolescent With Marfan Syndrome.
We discuss an adolescent with Marfan syndrome and a previous aortic valve-sparing root replacement who was found to have mitral annular disjunction on surveillance cardiac imaging in the setting of recurrent p... | ATENOLOL, LOSARTAN POTASSIUM | DrugsGivenReaction | CC BY-NC-ND | 34693358 | 20,461,693 | 2021-10-06 |
What was the administration route of drug 'LOSARTAN POTASSIUM'? | Mitral Annular Disjunction Associated With Fatal Ventricular Arrhythmia in an Adolescent With Marfan Syndrome.
We discuss an adolescent with Marfan syndrome and a previous aortic valve-sparing root replacement who was found to have mitral annular disjunction on surveillance cardiac imaging in the setting of recurrent p... | Oral | DrugAdministrationRoute | CC BY-NC-ND | 34693358 | 20,461,693 | 2021-10-06 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Cytomegalovirus pericarditis'. | Brentuximab vedotin consolidation after autologous stem cell transplantation for Hodgkin lymphoma: A Fondazione Italiana Linfomi real-life experience.
The standard management for relapsed or refractory classical Hodgkin lymphoma (cHL) is salvage therapy followed by autologous stem cell transplantation (ASCT). This stra... | BENDAMUSTINE, BRENTUXIMAB VEDOTIN | DrugsGivenReaction | CC BY | 34694649 | 20,050,447 | 2021-10-25 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Diarrhoea'. | Brentuximab vedotin consolidation after autologous stem cell transplantation for Hodgkin lymphoma: A Fondazione Italiana Linfomi real-life experience.
The standard management for relapsed or refractory classical Hodgkin lymphoma (cHL) is salvage therapy followed by autologous stem cell transplantation (ASCT). This stra... | BENDAMUSTINE, BRENTUXIMAB VEDOTIN | DrugsGivenReaction | CC BY | 34694649 | 20,050,447 | 2021-10-25 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Febrile neutropenia'. | Brentuximab vedotin consolidation after autologous stem cell transplantation for Hodgkin lymphoma: A Fondazione Italiana Linfomi real-life experience.
The standard management for relapsed or refractory classical Hodgkin lymphoma (cHL) is salvage therapy followed by autologous stem cell transplantation (ASCT). This stra... | BENDAMUSTINE, BRENTUXIMAB VEDOTIN | DrugsGivenReaction | CC BY | 34694649 | 20,050,447 | 2021-10-25 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Klebsiella infection'. | Brentuximab vedotin consolidation after autologous stem cell transplantation for Hodgkin lymphoma: A Fondazione Italiana Linfomi real-life experience.
The standard management for relapsed or refractory classical Hodgkin lymphoma (cHL) is salvage therapy followed by autologous stem cell transplantation (ASCT). This stra... | BENDAMUSTINE, BRENTUXIMAB VEDOTIN | DrugsGivenReaction | CC BY | 34694649 | 20,050,447 | 2021-10-25 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Klebsiella sepsis'. | Brentuximab vedotin consolidation after autologous stem cell transplantation for Hodgkin lymphoma: A Fondazione Italiana Linfomi real-life experience.
The standard management for relapsed or refractory classical Hodgkin lymphoma (cHL) is salvage therapy followed by autologous stem cell transplantation (ASCT). This stra... | BENDAMUSTINE, BRENTUXIMAB VEDOTIN | DrugsGivenReaction | CC BY | 34694649 | 20,050,447 | 2021-10-25 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Nausea'. | Brentuximab vedotin consolidation after autologous stem cell transplantation for Hodgkin lymphoma: A Fondazione Italiana Linfomi real-life experience.
The standard management for relapsed or refractory classical Hodgkin lymphoma (cHL) is salvage therapy followed by autologous stem cell transplantation (ASCT). This stra... | BENDAMUSTINE, BRENTUXIMAB VEDOTIN | DrugsGivenReaction | CC BY | 34694649 | 20,050,447 | 2021-10-25 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Neuropathy peripheral'. | Brentuximab vedotin consolidation after autologous stem cell transplantation for Hodgkin lymphoma: A Fondazione Italiana Linfomi real-life experience.
The standard management for relapsed or refractory classical Hodgkin lymphoma (cHL) is salvage therapy followed by autologous stem cell transplantation (ASCT). This stra... | BENDAMUSTINE, BRENTUXIMAB VEDOTIN | DrugsGivenReaction | CC BY | 34694649 | 20,050,447 | 2021-10-25 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Neutropenia'. | Brentuximab vedotin consolidation after autologous stem cell transplantation for Hodgkin lymphoma: A Fondazione Italiana Linfomi real-life experience.
The standard management for relapsed or refractory classical Hodgkin lymphoma (cHL) is salvage therapy followed by autologous stem cell transplantation (ASCT). This stra... | BENDAMUSTINE, BRENTUXIMAB VEDOTIN | DrugsGivenReaction | CC BY | 34694649 | 20,050,447 | 2021-10-25 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Pneumonia cytomegaloviral'. | Brentuximab vedotin consolidation after autologous stem cell transplantation for Hodgkin lymphoma: A Fondazione Italiana Linfomi real-life experience.
The standard management for relapsed or refractory classical Hodgkin lymphoma (cHL) is salvage therapy followed by autologous stem cell transplantation (ASCT). This stra... | BENDAMUSTINE, BRENTUXIMAB VEDOTIN | DrugsGivenReaction | CC BY | 34694649 | 20,050,447 | 2021-10-25 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Pneumonia influenzal'. | Brentuximab vedotin consolidation after autologous stem cell transplantation for Hodgkin lymphoma: A Fondazione Italiana Linfomi real-life experience.
The standard management for relapsed or refractory classical Hodgkin lymphoma (cHL) is salvage therapy followed by autologous stem cell transplantation (ASCT). This stra... | BENDAMUSTINE, BRENTUXIMAB VEDOTIN | DrugsGivenReaction | CC BY | 34694649 | 20,050,447 | 2021-10-25 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Product use issue'. | Brentuximab vedotin consolidation after autologous stem cell transplantation for Hodgkin lymphoma: A Fondazione Italiana Linfomi real-life experience.
The standard management for relapsed or refractory classical Hodgkin lymphoma (cHL) is salvage therapy followed by autologous stem cell transplantation (ASCT). This stra... | BENDAMUSTINE, BRENTUXIMAB VEDOTIN | DrugsGivenReaction | CC BY | 34694649 | 20,050,447 | 2021-10-25 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Pyrexia'. | Brentuximab vedotin consolidation after autologous stem cell transplantation for Hodgkin lymphoma: A Fondazione Italiana Linfomi real-life experience.
The standard management for relapsed or refractory classical Hodgkin lymphoma (cHL) is salvage therapy followed by autologous stem cell transplantation (ASCT). This stra... | BENDAMUSTINE, BRENTUXIMAB VEDOTIN | DrugsGivenReaction | CC BY | 34694649 | 20,050,447 | 2021-10-25 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Rash'. | Brentuximab vedotin consolidation after autologous stem cell transplantation for Hodgkin lymphoma: A Fondazione Italiana Linfomi real-life experience.
The standard management for relapsed or refractory classical Hodgkin lymphoma (cHL) is salvage therapy followed by autologous stem cell transplantation (ASCT). This stra... | BENDAMUSTINE, BRENTUXIMAB VEDOTIN | DrugsGivenReaction | CC BY | 34694649 | 20,050,447 | 2021-10-25 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Spinal pain'. | Brentuximab vedotin consolidation after autologous stem cell transplantation for Hodgkin lymphoma: A Fondazione Italiana Linfomi real-life experience.
The standard management for relapsed or refractory classical Hodgkin lymphoma (cHL) is salvage therapy followed by autologous stem cell transplantation (ASCT). This stra... | BENDAMUSTINE, BRENTUXIMAB VEDOTIN | DrugsGivenReaction | CC BY | 34694649 | 20,050,447 | 2021-10-25 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Thrombocytopenia'. | Brentuximab vedotin consolidation after autologous stem cell transplantation for Hodgkin lymphoma: A Fondazione Italiana Linfomi real-life experience.
The standard management for relapsed or refractory classical Hodgkin lymphoma (cHL) is salvage therapy followed by autologous stem cell transplantation (ASCT). This stra... | BENDAMUSTINE, BRENTUXIMAB VEDOTIN | DrugsGivenReaction | CC BY | 34694649 | 20,050,447 | 2021-10-25 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Treatment failure'. | Brentuximab vedotin consolidation after autologous stem cell transplantation for Hodgkin lymphoma: A Fondazione Italiana Linfomi real-life experience.
The standard management for relapsed or refractory classical Hodgkin lymphoma (cHL) is salvage therapy followed by autologous stem cell transplantation (ASCT). This stra... | BENDAMUSTINE, BRENTUXIMAB VEDOTIN | DrugsGivenReaction | CC BY | 34694649 | 20,050,447 | 2021-10-25 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Vomiting'. | Brentuximab vedotin consolidation after autologous stem cell transplantation for Hodgkin lymphoma: A Fondazione Italiana Linfomi real-life experience.
The standard management for relapsed or refractory classical Hodgkin lymphoma (cHL) is salvage therapy followed by autologous stem cell transplantation (ASCT). This stra... | BENDAMUSTINE, BRENTUXIMAB VEDOTIN | DrugsGivenReaction | CC BY | 34694649 | 20,050,447 | 2021-10-25 |
What was the dosage of drug 'BRENTUXIMAB VEDOTIN'? | Brentuximab vedotin consolidation after autologous stem cell transplantation for Hodgkin lymphoma: A Fondazione Italiana Linfomi real-life experience.
The standard management for relapsed or refractory classical Hodgkin lymphoma (cHL) is salvage therapy followed by autologous stem cell transplantation (ASCT). This stra... | 1.8 MG/KG, Q3WEEKS UP TO 16 DOSES | DrugDosageText | CC BY | 34694649 | 20,050,447 | 2021-10-25 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Acanthoma'. | Safety and efficacy of combining biologics or small molecules for inflammatory bowel disease or immune-mediated inflammatory diseases: A European retrospective observational study.
OBJECTIVE
Few data are available regarding the combination of biologics or small molecules in inflammatory bowel disease (IBD) patients. We... | ADALIMUMAB, APREMILAST, METHOTREXATE, MYCOPHENOLATE MOFETIL | DrugsGivenReaction | CC BY-NC-ND | 34694746 | 20,060,224 | 2021-10-25 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Angioedema'. | Safety and efficacy of combining biologics or small molecules for inflammatory bowel disease or immune-mediated inflammatory diseases: A European retrospective observational study.
OBJECTIVE
Few data are available regarding the combination of biologics or small molecules in inflammatory bowel disease (IBD) patients. We... | ADALIMUMAB, APREMILAST, METHOTREXATE, MYCOPHENOLATE MOFETIL | DrugsGivenReaction | CC BY-NC-ND | 34694746 | 20,060,224 | 2021-10-25 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Ankle fracture'. | Safety and efficacy of combining biologics or small molecules for inflammatory bowel disease or immune-mediated inflammatory diseases: A European retrospective observational study.
OBJECTIVE
Few data are available regarding the combination of biologics or small molecules in inflammatory bowel disease (IBD) patients. We... | ADALIMUMAB, APREMILAST, METHOTREXATE, MYCOPHENOLATE MOFETIL | DrugsGivenReaction | CC BY-NC-ND | 34694746 | 20,060,224 | 2021-10-25 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Atrial fibrillation'. | Safety and efficacy of combining biologics or small molecules for inflammatory bowel disease or immune-mediated inflammatory diseases: A European retrospective observational study.
OBJECTIVE
Few data are available regarding the combination of biologics or small molecules in inflammatory bowel disease (IBD) patients. We... | ADALIMUMAB, APREMILAST, METHOTREXATE, MYCOPHENOLATE MOFETIL | DrugsGivenReaction | CC BY-NC-ND | 34694746 | 20,060,224 | 2021-10-25 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Campylobacter colitis'. | Safety and efficacy of combining biologics or small molecules for inflammatory bowel disease or immune-mediated inflammatory diseases: A European retrospective observational study.
OBJECTIVE
Few data are available regarding the combination of biologics or small molecules in inflammatory bowel disease (IBD) patients. We... | ADALIMUMAB, APREMILAST, METHOTREXATE, MYCOPHENOLATE MOFETIL | DrugsGivenReaction | CC BY-NC-ND | 34694746 | 20,060,224 | 2021-10-25 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Cholangitis sclerosing'. | Safety and efficacy of combining biologics or small molecules for inflammatory bowel disease or immune-mediated inflammatory diseases: A European retrospective observational study.
OBJECTIVE
Few data are available regarding the combination of biologics or small molecules in inflammatory bowel disease (IBD) patients. We... | ADALIMUMAB, APREMILAST, METHOTREXATE, MYCOPHENOLATE MOFETIL | DrugsGivenReaction | CC BY-NC-ND | 34694746 | 20,060,224 | 2021-10-25 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Condition aggravated'. | Safety and efficacy of combining biologics or small molecules for inflammatory bowel disease or immune-mediated inflammatory diseases: A European retrospective observational study.
OBJECTIVE
Few data are available regarding the combination of biologics or small molecules in inflammatory bowel disease (IBD) patients. We... | ADALIMUMAB, APREMILAST, METHOTREXATE, MYCOPHENOLATE MOFETIL | DrugsGivenReaction | CC BY-NC-ND | 34694746 | 20,060,224 | 2021-10-25 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Drug intolerance'. | Safety and efficacy of combining biologics or small molecules for inflammatory bowel disease or immune-mediated inflammatory diseases: A European retrospective observational study.
OBJECTIVE
Few data are available regarding the combination of biologics or small molecules in inflammatory bowel disease (IBD) patients. We... | ADALIMUMAB, APREMILAST, METHOTREXATE, MYCOPHENOLATE MOFETIL | DrugsGivenReaction | CC BY-NC-ND | 34694746 | 20,060,224 | 2021-10-25 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Inflammatory bowel disease'. | Safety and efficacy of combining biologics or small molecules for inflammatory bowel disease or immune-mediated inflammatory diseases: A European retrospective observational study.
OBJECTIVE
Few data are available regarding the combination of biologics or small molecules in inflammatory bowel disease (IBD) patients. We... | ADALIMUMAB, APREMILAST, METHOTREXATE, MYCOPHENOLATE MOFETIL | DrugsGivenReaction | CC BY-NC-ND | 34694746 | 20,060,224 | 2021-10-25 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Meningoencephalitis herpetic'. | Safety and efficacy of combining biologics or small molecules for inflammatory bowel disease or immune-mediated inflammatory diseases: A European retrospective observational study.
OBJECTIVE
Few data are available regarding the combination of biologics or small molecules in inflammatory bowel disease (IBD) patients. We... | CERTOLIZUMAB PEGOL, METHOTREXATE, VEDOLIZUMAB | DrugsGivenReaction | CC BY-NC-ND | 34694746 | 20,408,699 | 2021-10-25 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Osteomyelitis'. | Safety and efficacy of combining biologics or small molecules for inflammatory bowel disease or immune-mediated inflammatory diseases: A European retrospective observational study.
OBJECTIVE
Few data are available regarding the combination of biologics or small molecules in inflammatory bowel disease (IBD) patients. We... | ADALIMUMAB, APREMILAST, METHOTREXATE, MYCOPHENOLATE MOFETIL | DrugsGivenReaction | CC BY-NC-ND | 34694746 | 20,060,224 | 2021-10-25 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Pneumonia'. | Safety and efficacy of combining biologics or small molecules for inflammatory bowel disease or immune-mediated inflammatory diseases: A European retrospective observational study.
OBJECTIVE
Few data are available regarding the combination of biologics or small molecules in inflammatory bowel disease (IBD) patients. We... | INFLIXIMAB, METHOTREXATE, VEDOLIZUMAB | DrugsGivenReaction | CC BY-NC-ND | 34694746 | 20,596,224 | 2021-10-25 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Therapeutic product effect decreased'. | Safety and efficacy of combining biologics or small molecules for inflammatory bowel disease or immune-mediated inflammatory diseases: A European retrospective observational study.
OBJECTIVE
Few data are available regarding the combination of biologics or small molecules in inflammatory bowel disease (IBD) patients. We... | ADALIMUMAB, APREMILAST, METHOTREXATE, MYCOPHENOLATE MOFETIL | DrugsGivenReaction | CC BY-NC-ND | 34694746 | 20,060,224 | 2021-10-25 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Therapy non-responder'. | Safety and efficacy of combining biologics or small molecules for inflammatory bowel disease or immune-mediated inflammatory diseases: A European retrospective observational study.
OBJECTIVE
Few data are available regarding the combination of biologics or small molecules in inflammatory bowel disease (IBD) patients. We... | ADALIMUMAB, APREMILAST, METHOTREXATE, MYCOPHENOLATE MOFETIL | DrugsGivenReaction | CC BY-NC-ND | 34694746 | 20,060,224 | 2021-10-25 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Viral upper respiratory tract infection'. | Safety and efficacy of combining biologics or small molecules for inflammatory bowel disease or immune-mediated inflammatory diseases: A European retrospective observational study.
OBJECTIVE
Few data are available regarding the combination of biologics or small molecules in inflammatory bowel disease (IBD) patients. We... | ADALIMUMAB, APREMILAST, METHOTREXATE, MYCOPHENOLATE MOFETIL | DrugsGivenReaction | CC BY-NC-ND | 34694746 | 20,060,224 | 2021-10-25 |
What was the administration route of drug 'INFLIXIMAB'? | Safety and efficacy of combining biologics or small molecules for inflammatory bowel disease or immune-mediated inflammatory diseases: A European retrospective observational study.
OBJECTIVE
Few data are available regarding the combination of biologics or small molecules in inflammatory bowel disease (IBD) patients. We... | Subcutaneous | DrugAdministrationRoute | CC BY-NC-ND | 34694746 | 20,596,224 | 2021-10-25 |
What was the administration route of drug 'USTEKINUMAB'? | Safety and efficacy of combining biologics or small molecules for inflammatory bowel disease or immune-mediated inflammatory diseases: A European retrospective observational study.
OBJECTIVE
Few data are available regarding the combination of biologics or small molecules in inflammatory bowel disease (IBD) patients. We... | Subcutaneous | DrugAdministrationRoute | CC BY-NC-ND | 34694746 | 20,573,310 | 2021-10-25 |
What was the dosage of drug 'INFLIXIMAB'? | Safety and efficacy of combining biologics or small molecules for inflammatory bowel disease or immune-mediated inflammatory diseases: A European retrospective observational study.
OBJECTIVE
Few data are available regarding the combination of biologics or small molecules in inflammatory bowel disease (IBD) patients. We... | UNK, STANDARD DOSE | DrugDosageText | CC BY-NC-ND | 34694746 | 20,596,224 | 2021-10-25 |
What was the dosage of drug 'VEDOLIZUMAB'? | Safety and efficacy of combining biologics or small molecules for inflammatory bowel disease or immune-mediated inflammatory diseases: A European retrospective observational study.
OBJECTIVE
Few data are available regarding the combination of biologics or small molecules in inflammatory bowel disease (IBD) patients. We... | UNK, STANDARD DOSE | DrugDosageText | CC BY-NC-ND | 34694746 | 20,596,224 | 2021-10-25 |
What was the outcome of reaction 'Cholangitis sclerosing'? | Safety and efficacy of combining biologics or small molecules for inflammatory bowel disease or immune-mediated inflammatory diseases: A European retrospective observational study.
OBJECTIVE
Few data are available regarding the combination of biologics or small molecules in inflammatory bowel disease (IBD) patients. We... | Recovered | ReactionOutcome | CC BY-NC-ND | 34694746 | 20,060,224 | 2021-10-25 |
What was the outcome of reaction 'Meningoencephalitis herpetic'? | Safety and efficacy of combining biologics or small molecules for inflammatory bowel disease or immune-mediated inflammatory diseases: A European retrospective observational study.
OBJECTIVE
Few data are available regarding the combination of biologics or small molecules in inflammatory bowel disease (IBD) patients. We... | Recovered | ReactionOutcome | CC BY-NC-ND | 34694746 | 20,408,699 | 2021-10-25 |
What was the outcome of reaction 'Oesophageal candidiasis'? | Safety and efficacy of combining biologics or small molecules for inflammatory bowel disease or immune-mediated inflammatory diseases: A European retrospective observational study.
OBJECTIVE
Few data are available regarding the combination of biologics or small molecules in inflammatory bowel disease (IBD) patients. We... | Recovered | ReactionOutcome | CC BY-NC-ND | 34694746 | 20,573,310 | 2021-10-25 |
What was the outcome of reaction 'Osteomyelitis'? | Safety and efficacy of combining biologics or small molecules for inflammatory bowel disease or immune-mediated inflammatory diseases: A European retrospective observational study.
OBJECTIVE
Few data are available regarding the combination of biologics or small molecules in inflammatory bowel disease (IBD) patients. We... | Recovered | ReactionOutcome | CC BY-NC-ND | 34694746 | 20,060,224 | 2021-10-25 |
What was the outcome of reaction 'Pneumonia'? | Safety and efficacy of combining biologics or small molecules for inflammatory bowel disease or immune-mediated inflammatory diseases: A European retrospective observational study.
OBJECTIVE
Few data are available regarding the combination of biologics or small molecules in inflammatory bowel disease (IBD) patients. We... | Recovered | ReactionOutcome | CC BY-NC-ND | 34694746 | 20,596,224 | 2021-10-25 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Erythema'. | Advanced Leiomyosarcoma of the Retroperitoneal Space in a Kidney Transplant Recipient with a History of Peritoneal Dialysis: A Case Report.
BACKGROUND Leiomyosarcoma frequently occurs in patients who are on immunosuppressive therapy. It is the second most common sarcoma in this population and is often associated with E... | BASILIXIMAB, DOCETAXEL, GEMCITABINE, MYCOPHENOLATE SODIUM, PREDNISONE, TACROLIMUS | DrugsGivenReaction | CC BY-NC-ND | 34695070 | 20,192,442 | 2021-10-25 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Leiomyosarcoma metastatic'. | Advanced Leiomyosarcoma of the Retroperitoneal Space in a Kidney Transplant Recipient with a History of Peritoneal Dialysis: A Case Report.
BACKGROUND Leiomyosarcoma frequently occurs in patients who are on immunosuppressive therapy. It is the second most common sarcoma in this population and is often associated with E... | MYCOPHENOLATE MOFETIL, PREDNISONE, TACROLIMUS | DrugsGivenReaction | CC BY-NC-ND | 34695070 | 20,099,836 | 2021-10-25 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Off label use'. | Advanced Leiomyosarcoma of the Retroperitoneal Space in a Kidney Transplant Recipient with a History of Peritoneal Dialysis: A Case Report.
BACKGROUND Leiomyosarcoma frequently occurs in patients who are on immunosuppressive therapy. It is the second most common sarcoma in this population and is often associated with E... | DOCETAXEL, GEMCITABINE HYDROCHLORIDE | DrugsGivenReaction | CC BY-NC-ND | 34695070 | 20,085,137 | 2021-10-25 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Product use in unapproved indication'. | Advanced Leiomyosarcoma of the Retroperitoneal Space in a Kidney Transplant Recipient with a History of Peritoneal Dialysis: A Case Report.
BACKGROUND Leiomyosarcoma frequently occurs in patients who are on immunosuppressive therapy. It is the second most common sarcoma in this population and is often associated with E... | DOCETAXEL, GEMCITABINE | DrugsGivenReaction | CC BY-NC-ND | 34695070 | 20,146,706 | 2021-10-25 |
Subsets and Splits
No community queries yet
The top public SQL queries from the community will appear here once available.